NSF KARİYER 0744556 (Rao) ve VCU HHMI Bilim Eğitim ve Araştırma Programı (Pascual) aracılığıyla burs tarafından bu iş için kısmi finansman sağlandı.

Bölüm 1: Süspansiyon İmmünositokimyasal Boyama <ol><li> Hücreler tek bir hücre süspansiyonu hasat edilir. </li><li> Bu hücreler daha sonra 1.5 2mL mikrosantrifüj tüpler aktarılır ve 200g 4 dakika santrifüj. </li><li> Hücreler supernatant dışarı aspire tarafından yıkanır, PBS 1mL yeniden askıya - (Mg 2 olmadan + ve Ca 2 +) ve sonra 4 dakika için 200 gr tekrar santrifüj. Bu iki kez yapılmalıdır. </li><li> Yıkadıktan sonra, hücreler daha sonra yeniden askıya onlara 10 dakika boyunca oda sıcaklığında 1 ml% 4 paraformaldehid (PFA) tarafından sabitlenir. </li><li> Hücreler iki kez 1ml PBS tekrar yıkanır. </li><li> Yıkama, blok hücreleri sonra yeniden askıya Blok Çözüm 1 ml (% 6 serum/94% PBS). 45 dakika oda sıcaklığında inkübe edin. </li><li> 200 gr az 4 dakika sonra, tüpler santrifüj ve Blok Çözüm aspirat. Primer antikor çözeltisi (Blok Çözüm tavsiye seyreltme ile yapılan) 1ml hücreleri yeniden askıya. Hücreler ya 1 saat veya 4 ° C&#39;de bir gece bir sonraki adıma geçmeden önce oda sıcaklığında inkübe edilebilir. </li><li> Hücreler daha sonra Blok Çözüm 1mL ile iki kez yıkanır. </li><li> Sekonder antikoru çözümü (tavsiye edilen seyreltme Blok Çözüm ile yapılan) ve oda sıcaklığında 1 saat süreyle inkübe 1mL hücreleri yeniden askıya sonra. </li><li> 1 saat sonra, hücreler daha sonra Blok Çözüm 1mL ile iki kez tekrar yıkanmış olmalıdır. </li><li> Blok Çözüm ile yıkadıktan sonra, 1 ml PBS ile tekrar hücreleri yıkayın. </li><li> Çeşitli yıkar sonra, 1 ml hücrelerin yeniden askıya DAPI nükleer leke (PBS içinde DAPI 1:10,000 seyreltme -) ve oda sıcaklığında 5 dakika inkübe edin. </li><li> 5 dakika sonra, 4 dakika için 200 gr tüpler santrifüj. - 1 ml PBS DAPI nükleer leke çözüm ve yeniden askıya hücreleri aspire. </li></ol> HPSCs Incorporation Bölüm 2: sitospin aparatı sayesinde üretilen slaytlar <ol><li> Plastik slaytlar, bir matkap basın delik istenilen miktarda yaparak hazırlanıyor. Kullanılmak üzere geniş çaplı mikropipet ucu (ler) den en fazla 1 mm daha geniş çaplı olması gerekir. </li><li> Filtre kağıdı, makas ile plastik slayt parametreleri kesilir. </li><li> Delik sonra filtre kağıdı yapılır. Deliğin boyutu (ler) mikropipet ucu (ler) aracılığıyla snuggly oturduğundan emin yeterince büyük olmalıdır. </li><li> Sonra, hazırlanan plastik slaytlar bir üst ve alt kesilmiş filtre kağıdı (Şekil 1) yerleştirilmiş bir cam slayt üzerine yerleştirilir. Katmanları bant ile sabitlenir. </li><li> Bölüm 1 lekeli hücre süspansiyonu 100μL maksimum (istenilen tek tabaka yoğunluğuna bağlı olarak) daha sonra mikropipet ucu (lar) üstüne yerleştirilir. </li><li> Gerekirse, cihazı hücre çözümü ile tartılır ve benzer ağırlıkta bir karşı denge oluşturulmuş. </li><li> Sitospin aparatı ve dengelemek sonra bir masaüstü santrifüj yerleştirilir ve 200g 4 dakika santrifüj yapabilirsiniz. </li><li> Santrifüj sonra, sitospin aparat dikkatle cam slayt hücreler yerinden doesnt bir şekilde demonte. </li><li> Gerekirse, aşırı çevreleyen PBS - cam tarafında aspire. </li><li> Hücreler daha sonra istediğiniz hücreye tek tabaka elde edilip edilmediğini kontrol etmek için bir floresan mikroskop kullanılarak görülebilir. </li></ol> Bölüm 3: Montaj slaytlar <ol><li> Bir damla istenen montaj medya hücreleri içeren her bölgenin merkezinde yer almaktadır. </li><li> Sonra, mümkünse hava kabarcıklarını önlemek için çalışıyoruz Slaytlarınıza bir kapak kayma yavaşça indirilir. </li><li> Aşırı montaj medya sonra slayt kaldırılır. </li><li> Sonra, kapak fişleri iki tırnak cilası ile mühürlenir. </li><li> Slaytlar sonuçları gözlemlenen ve belgelenen kadar karanlık bir depolama alanı saklanabilir. </li></ol>

<ol>
	<li>Rao, R. R., Johnson, A. V., Stice, S. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cell+surface+markers+in+human+embryonic+stem+cells.">Cell surface markers in human embryonic stem cells.</a> Methods in Mol. Bio. - Stem Cell Assays. 407, 51-61 (2007).</li><li>Sisino, G., Bellavia, D., Corallo, M., Geraci, F., Barbieri, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+homemade+cytospin+apparatus.">A homemade cytospin apparatus.</a> Anal. Biochem. 359, 283-284 (2006).</li></ol>

Laboratuvar amaçları için, 35mm, fare embriyonik fibroblastlar (MEFS) yetişen kök hücre kültürleri bir çanak immünositokimyasal boyama prosedürü için sitospin aparatı ile kullanım için ayrılmıştır. Hücreler daha sonra bir tek hücre süspansiyonu, MEF katmanı mümkün olduğu kadar çok kaldırarak, Pasajlanması enzimatik yoluyla tahsil edilir. MEF katman daha etkili kök hücre izolasyonu isteniyorsa, koloniler elle süspansiyon içine sindirilmiş sonra aldı olabilir. Besleyici ücretsiz koşul...

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">	
		
		<div>
		<table border="1">
		<thead>
		<tr>
		<th>Material Name</th>
		<th>Type</th>
		<th>Company</th>
		<th>Catalogue Number</th>
		<th>Comment</th>
		</tr>
		</thead>
		<tbody>
		
<tr>
<td>Lab Tek Permanox Chamber Slide</td>
<td>&nbsp;</td>
<td>Thermo Fisher Scientific</td>
<td>117437</td>
<td>Material for re-used plastic slides</td>
</tr>
<tr>
<td>Superfrost/Plus Microscope Slides Precleaned</td>
<td>&nbsp;</td>
<td>Fisher Scientific</td>
<td>12-550-15</td>
<td>&nbsp;</td>
<tr>
<td>0.1-10&mu;L Filter Tips</td>
<td>&nbsp;</td>
<td>USA Scientific</td>
<td>1121-3810</td>
<td>&nbsp;</td>
<tr>
<td>Microscope Cover Glass</td>
<td>&nbsp;</td>
<td>Fisher Scientific</td>
<td>120542-B</td>
<td>&nbsp;</td>
<tr>
<td>Cytoseal 280</td>
<td>&nbsp;</td>
<td>Richard-Allan Scientific</td>
<td>8311-4</td>
<td>Mounting Medium</td>
</tr>
<tr>
<td>DPBS</td>
<td>&nbsp;</td>
<td>Gibco</td>
<td>14190</td>
<td>&nbsp;</td>
<tr>
<td>Normal Goat Serum</td>
<td>&nbsp;</td>
<td>Invitrogen</td>
<td>10000C</td>
<td>&nbsp;</td>
<tr>
<td>Mouse Anti-SSEA-4 Monoclonal Antibody</td>
<td>&nbsp;</td>
<td>Millipore/Chemicon</td>
<td>MAB4304</td>
<td>Primary Antibody for SSEA-4 staining</td>
</tr>
<tr>
<td>Rat Anti-SSEA-3 Monoclonal Antibody</td>
<td>&nbsp;</td>
<td>Millipore/Chemicon</td>
<td>MAB4303</td>
<td>Primary Antibody for SSEA-3 staining</td>
</tr>
<tr>
<td>Alexa Fluor 488 Goat Anti-Mouse IgG</td>
<td>&nbsp;</td>
<td>Invitrogen/ Molecular Probes</td>
<td>A11029</td>
<td>Secondary Antibody for SSEA-4 staining</td>
</tr>
<tr>
<td>Alexa Fluor 488 Labeled Goat Anti-Rat IgG </td>
<td>&nbsp;</td>
<td>Invitrogen/ Molecular Probes</td>
<td>A11006</td>
<td>Secondary Antibody for SSEA-3 staining</td>
</tr>
<tr>
<td>DAPI, Dihydrochloride</td>
<td>&nbsp;</td>
<td>CalBioChem</td>
<td>268298</td>
<td>&nbsp;</td>		</tbody>
		</table>
		</div>

immunocytochemical analysis of human pluripotent stem cells using a self-made cytospin apparatus

Insan embriyonik kök hücreleri (hESC) ve insan kaynaklı pluripotent kök hücreleri (hiPSCs) İnsan pluripotent kök hücreleri (hPSCs) sınırsız kendini yenileme yetenekleri ve çok sayıda hücre tipleri ayırt etmek için potansiyel nedeniyle heyecan verici hücre kaynaklarıdır. HPSCs pluripotent devlet qPCR, immünsitokimya gibi teknikler genellikle değerlendirilen ve diğer<em&gt; In vitro</em&gt; Ve<em&gt; In vivo</em&gt; Birden çok hücre tiplerine farklılaşma stratejileri. Bunlar arasında, immünositokimyasal teknikleri aday hücre içi ve hücre yüzeyi biyobelirteçleri analizine dayalı hPSCs farklılaşmamış devletin rutin karakterizasyonu için geliştirilmiştir. Koloniler, sorunları rutin olarak tek tek hücre düzeyinde bu belirteçlerin ifade nicel olarak ortaya çıkan hPSCs büyüdüğünü göz önüne alındığında. Flow sitometri analizleri, bu sorunu ancak hücre sayıları ve normal, hPSC kültürlerin rutin kalite kontrol değerlendirmesi için elverişli değildir reaktifler kullanımı için hizmet vermektedir. Böylece, belirteç değerlendirilmesi için bütünlüğü korunmuş tek tabaka hücre örnekleri oluşturmak pratik ve tekrarlanabilir araçlarının geliştirilmesi, kök hücre araştırmaları pek çok avantajı vardır. Tek tek hücrelerin tek tabaka kolayca gözlenir ve spesifik belirteçler ifade için nicel olabilir, çünkü bu, immünositokimyasal analiz büyük ölçüde yarar sağlar. Bu hedefe doğru, self-made sitospin aparat inşa edildi ve immünositokimyasal boyama ile kullanım için optimize edilmiş. İki hücre yüzey belirteçleri (SSEA3/SSEA4) ifadesi için bir varyantı BG01 Bu protokolün amacı, kök hücre hattı analiz edildi.

Watch this Scientific Journal Video about Immunocytochemical Analysis of Human Pluripotent Stem Cells using a Self-Made Cytospin Apparatus at JoVE.com

Immunocytochemical Analysis of Human Pluripotent Stem Cells using a Self-Made Cytospin Apparatus

Gözlem ve ölçümü için bir tek tabaka hücreleri oluşturmak için bir self-made sitospin cihazların kullanımı dayalı, insan pluripotent kök hücreleri hücre yüzey belirteçleri için Süspansiyon immünositokimyasal boyama (hPSCs) (SSEA-3/SSEA-4) elde edildi.

Self-Made sitospin Aparatı kullanarak İnsan Pluripotent Kök Hücre İmmünositokimyasal Analizi

Human pluripotent stem cells (hPSCs) that include human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) are exciting cell ...

immunocytochemical-analysis-human-pluripotent-stem-cells-using-self

Research

JoVE Journal

Biology

14.2K Görüntüleme.  Virginia Commonwealth University. Gözlem ve ölçümü için bir tek tabaka hücreleri oluşturmak için bir self-made sitospin cihazların kullanımı dayalı, insan pluripotent kök hücreleri hücre yüzey belirteçleri için Süspansiyon immünositokimyasal boyama (hPSCs) (SSEA-3/SSEA-4) elde edildi.

Video: Immunocytochemical Analysis of Human Pluripotent Stem Cells using a Self-Made Cytospin Apparatus

Derivation of Human Embryonic Stem Cells by Immunosurgery

The ability of human embryonic stem cells to self-renew and differentiate into all cell types of 
the body suggests that they hold great promise for both medical applications and as a research 
tool for addressing fundamental questions in development and disease. Here, we provide a 
concise, step-by-step protocol for the derivation of human embryonic stem cells from embryos 
by immunosurgical isolation of the inner cell mass. 


The ability of human embryonic stem cells to self-renew and differentiate into all cell types of 
the body suggests that they hold great promise for both medical applications and as a research 
tool for addressing fundamental questions in development and disease. Here, we provide a 
concise, step-by-step protocol for the derivation of human embryonic stem cells from embryos 
by immunosurgical isolation of the inner cell mass.

Immunosurgery İnsan Embriyonik Kök Hücreleri türetilmesi

The ability of human embryonic stem cells to self-renew and differentiate into all cell types of 
the body suggests that they hold great promise for both ...

Biyoloji

Analysis of Pluripotent Stem Cells by using Cryosections of Embryoid Bodies

Embryonic stem (ES) cells are pluripotent cells derived from the inner cell mass of blastocyst-stage early mammalian embryos 1. A crucial stage in the differentiation of ES cells is the formation of embryoid bodies (EBs) aggregates 2, 3. EB formation is based on spontaneous aggregation when ES cells are cultured in non adherent plates. Three-dimensional EB recapitulates many aspects of early mammalian embryogenesis and differentiate into the three germ layers: ectoderm, mesoderm and endoderm 4.
Immunofluorescence and in situ hybridization are widely used techniques for the detection of target proteins and mRNA present in cells of a tissue section 5, 6, 7. Here we present a simple technique to generate high quality cryosections of embryoid bodies. This approach relies on the spatial orientation of EB embedding in OCT followed by the cryosection technique. The resulting sections can be subjected to a wide variety of analytical procedures in order to characterize populations of cells containing certain proteins, RNA or DNA. In this sense, the preparation of EB cryosections (10&mu;m) are essential tools for histology staining analysis (e.g. Hematoxilin and Eosin, DAPI), immunofluorescence (e.g. Oct4, nestin) or in situ hybridization. This technique can also help to understand aspects of embryogenesis with regards to the maintenance of the tri-dimensional spherical structure of EBs.

Pluripotent stem cells growing in suspension differentiate into embryoid bodies (EBs). Here we demonstrate how to obtain high quality EB cryosections useful for studying cellular and molecular aspects of embryogenesis, while preserving their organization as aggregates.

Embriyoid Kuruluşlar Cryosections kullanarak Pluripotent Kök Hücre Analizi

Embryonic stem (ES) cells are pluripotent cells derived from the inner cell mass of blastocyst-stage early mammalian embryos 1. A crucial stage in the ...

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Genetic modification is continuing to be an essential tool in studying stem cell biology and in setting forth potential clinical applications of human embryonic stem cells (HESCs)1. While improvements in several gene delivery methods have been described2-9, transfection remains a capricious process for HESCs, and has not yet been reported in human induced pluripotent stem cells (iPSCs). In this video, we demonstrate how our lab routinely transfects and nucleofects human iPSCs using plasmid with an enhanced green fluorescence protein (eGFP) reporter. Human iPSCs are adapted and maintained as feeder-free cultures to eliminate the possibility of feeder cell transfection and to allow efficient selection of stable transgenic iPSC clones following transfection. For nucleofection, human iPSCs are pre-treated with ROCK inhibitor11, trypsinized into small clumps of cells, nucleofected and replated on feeders in feeder cell-conditioned medium to enhance cell recovery. Transgene-expressing human iPSCs can be obtained after 6 hours. Antibiotic selection is applied after 24 hours and stable transgenic lines appear within 1 week. Our protocol is robust and reproducible for human iPSC lines without altering pluripotency of these cells.

Despite recent advancements in genetic modification, transfection of human embryonic stem cells (HESCs) remains a capricious process. To our knowledge, systematic and efficient methods to transfect human induced pluripotent stem cells (iPSCs) have not been reported. Here, we describe robust protocols to efficiently transfect and nucleofect human iPSCs.

İnsan İsteyerek Pluripotent Kök Hücreler transfekte ve Nucleofecting

Genetic modification is continuing to be an essential tool in studying stem cell biology and in setting forth potential clinical applications of human ...

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

To date, the lack of a suitable human cardiac cell source has been the major setback in regenerating the human myocardium, either by cell-based transplantation or by cardiac tissue engineering1-3. Cardiomyocytes become terminally-differentiated soon after birth and lose their ability to proliferate. There is no evidence that stem/progenitor cells derived from other sources, such as the bone marrow or the cord blood, are able to give rise to the contractile heart muscle cells following transplantation into the heart1-3. The need to regenerate or repair the damaged heart muscle has not been met by adult stem cell therapy, either endogenous or via cell delivery1-3. The genetically stable human embryonic stem cells (hESCs) have unlimited expansion ability and unrestricted plasticity, proffering a pluripotent reservoir for in vitro derivation of large supplies of human somatic cells that are restricted to the lineage in need of repair and regeneration4,5. Due to the prevalence of cardiovascular disease worldwide and acute shortage of donor organs, there is intense interest in developing hESC-based therapies as an alternative approach. However, how to channel the wide differentiation potential of pluripotent hESCs efficiently and predictably to a desired phenotype has been a major challenge for both developmental study and clinical translation. Conventional approaches rely on multi-lineage inclination of pluripotent cells through spontaneous germ layer differentiation, resulting in inefficient and uncontrollable lineage-commitment that is often followed by phenotypic heterogeneity and instability, hence, a high risk of tumorigenicity6-8 (see a schematic in Fig. 1A). In addition, undefined foreign/animal biological supplements and/or feeders that have typically been used for the isolation, expansion, and differentiation of hESCs may make direct use of such cell-specialized grafts in patients problematic9-11. To overcome these obstacles, we have resolved the elements of a defined culture system necessary and sufficient for sustaining the epiblast pluripotence of hESCs, serving as a platform for de novo derivation of clinically-suitable hESCs and effectively directing such hESCs uniformly towards clinically-relevant lineages by small molecules12 (see a schematic in Fig. 1B). After screening a variety of small molecules and growth factors, we found that such defined conditions rendered nicotinamide (NAM) sufficient to induce the specification of cardiomesoderm direct from pluripotent hESCs that further progressed to cardioblasts that generated human beating cardiomyocytes with high efficiency (Fig. 2). We defined conditions for induction of cardioblasts direct from pluripotent hESCs without an intervening multi-lineage embryoid body stage, enabling well-controlled efficient derivation of a large supply of human cardiac cells across the spectrum of developmental stages for cell-based therapeutics.

We have established a protocol for induction of cardioblasts direct from pluripotent human embryonic stem cells maintained under defined conditions with small molecules, which enables derivation of a large supply of human cardiac progenitors and functional cardiomyocytes for cardiovascular repair.

Küçük Molekül İndüksiyon Pluripotent İnsan Embriyonik Kök Hücreleri İnsan Kardiyak Öncüleri ve kardiyomiyositlerde Verimli türetilmesi

To date, the lack of a suitable human cardiac cell source has been the major setback in regenerating the human myocardium, either by cell-based ...

Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells (iPSCs) Using Retroviral Vector with GFP

Human embryonic stem cells (hESCs) are pluripotent and an invaluable cellular sources for in vitro disease modeling and regenerative medicine1. It has been previously shown that human somatic cells can be reprogrammed to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) and become induced pluripotent stem cells (iPSCs)2-4 . Like hESCs, human iPSCs are pluripotent and a potential source for autologous cells. Here we describe the protocol to reprogram human fibroblast cells with the four reprogramming factors cloned into GFP-containing retroviral backbone4. Using the following protocol, we generate human iPSCs in 3-4 weeks under human ESC culture condition. Human iPSC colonies closely resemble hESCs in morphology and display the loss of GFP fluorescence as a result of retroviral transgene silencing. iPSC colonies isolated mechanically under a fluorescence microscope behave in a similar fashion as hESCs. In these cells, we detect the expression of multiple pluripotency genes and surface markers.

Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells iPSCs Using Retroviral Vector with GFP

A method to generate human induced pluripotent stem cells (iPSCs) via retrovirus-mediated ectopic expression of OCT4, SOX2, KLF4 and MYC is described. A practical way to identify human iPSC colonies based on GFP expression is also discussed.

GFP Retroviral Vector kullanarak İsteyerek Pluripotent Kök Hücrelerinin (iPSCs) içine İnsan somatik hücreleri yeniden programlama

Human embryonic stem cells (hESCs) are pluripotent and an invaluable cellular sources for in vitro disease modeling and regenerative medicine1. It has ...

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Through the ectopic expression of four transcription factors, Oct4, Klf4, Sox2 and cMyc, human somatic cells can be converted to a pluripotent state, generating so-called induced pluripotent stem cells (iPSCs)1-4. Patient-specific iPSCs lack the ethical concerns that surround embryonic stem cells (ESCs) and would bypass possible immune rejection. Thus, iPSCs have attracted considerable attention for disease modeling studies, the screening of pharmacological compounds, and regenerative therapies5.
We have shown the generation of transgene-free human iPSCs from patients with different lung diseases using a single excisable polycistronic lentiviral Stem Cell Cassette (STEMCCA) encoding the Yamanaka factors6. These iPSC lines were generated from skin fibroblasts, the most common cell type used for reprogramming. Normally, obtaining fibroblasts requires a skin punch biopsy followed by expansion of the cells in culture for a few passages. Importantly, a number of groups have reported the reprogramming of human peripheral blood cells into iPSCs7-9. In one study, a Tet inducible version of the STEMCCA vector was employed9, which required the blood cells to be simultaneously infected with a constitutively active lentivirus encoding the reverse tetracycline transactivator. In contrast to fibroblasts, peripheral blood cells can be collected via minimally invasive procedures, greatly reducing the discomfort and distress of the patient. A simple and effective protocol for reprogramming blood cells using a constitutive single excisable vector may accelerate the application of iPSC technology by making it accessible to a broader research community. Furthermore, reprogramming of peripheral blood cells allows for the generation of iPSCs from individuals in which skin biopsies should be avoided (i.e. aberrant scarring) or due to pre-existing disease conditions preventing access to punch biopsies.
Here we demonstrate a protocol for the generation of human iPSCs from peripheral blood mononuclear cells (PBMCs) using a single floxed-excisable lentiviral vector constitutively expressing the 4 factors. Freshly collected or thawed PBMCs are expanded for 9 days as described10,11 in medium containing ascorbic acid, SCF, IGF-1, IL-3 and EPO before being transduced with the STEMCCA lentivirus. Cells are then plated onto MEFs and ESC-like colonies can be visualized two weeks after infection. Finally, selected clones are expanded and tested for the expression of the pluripotency markers SSEA-4, Tra-1-60 and Tra-1-81. This protocol is simple, robust and highly consistent, providing a reliable methodology for the generation of human iPSCs from readily accessible 4 ml of blood.

Here we show a simple and effective protocol for the generation of human iPSCs from 3-4 ml of peripheral blood using a single lentiviral reprogramming vector. Reprogramming of readily available blood cells promises to accelerate the utilization of iPSC technology by making it accessible to a broader research community.

STEMCCA lentiviral Vektör Kullanma Çevresel Blood İnsan İsteyerek Pluripotent Kök Hücre Üretimi

Through the ectopic expression of four transcription factors, Oct4, Klf4, Sox2 and cMyc, human somatic cells can be converted to a pluripotent state, ...

Rapid and Efficient Generation of Neurons from Human Pluripotent Stem Cells in a Multititre Plate Format

Existing protocols for the generation of neurons from human pluripotent stem cells (hPSCs) are often tedious in that they are multistep procedures involving the isolation and expansion of neural precursor cells, prior to terminal differentiation. In comparison to these time-consuming approaches, we have recently found that combined inhibition of three signaling pathways, TGF&beta;/SMAD2, BMP/SMAD1, and FGF/ERK, promotes rapid induction of neuroectoderm from hPSCs, followed by immediate differentiation into functional neurons. Here, we have adapted our procedure to a novel multititre plate format, to further enhance its reproducibility and to make it compatible with mid-throughput applications. It comprises four days of neuroectoderm formation in floating spheres (embryoid bodies), followed by a further four days of differentiation into neurons under adherent conditions. Most cells obtained with this protocol appear to be bipolar sensory neurons. Moreover, the procedure is highly efficient, does not require particular expert skills, and is based on a simple chemically defined medium with cost-efficient small molecules. Due to these features, the procedure may serve as a useful platform for further functional investigation as well as for cell-based screening approaches requiring human sensory neurons or neurons of any type.

Protocols for neuronal differentiation of pluripotent human stem cells (hPSCs) are often time-consuming and require substantial cell culture skills. Here, we have adapted a small molecule-based differentiation procedure to a multititre plate format, allowing simple, rapid, and efficient generation of human neurons in a controlled manner.

Bir Multititre Plaka Biçimi İnsan Pluripotent Kök Hücreler Nöron Hızlı ve Verimli Üretim

Existing protocols for the generation of neurons from human pluripotent stem cells (hPSCs) are often tedious in that they are  multistep procedures ...

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

In order to investigate the events driving heart development and to determine the molecular mechanisms leading to myocardial diseases in humans, it is essential first to generate functional human cardiomyocytes (CMs). The use of these cells in drug discovery and toxicology studies would also be highly beneficial, allowing new pharmacological molecules for the treatment of cardiac disorders to be validated pre-clinically on cells of human origin. Of the possible sources of CMs, induced pluripotent stem (iPS) cells are among the most promising, as they can be derived directly from readily accessible patient tissue and possess an intrinsic capacity to give rise to all cell types of the body 1. Several methods have been proposed for differentiating iPS cells into CMs, ranging from the classical embryoid bodies (EBs) aggregation approach to chemically defined protocols 2,3. In this article we propose an EBs-based protocol and show how this method can be employed to efficiently generate functional CM-like cells from feeder-free iPS cells.

Pluripotent stem cells, either embryonic or induced pluripotent stem (iPS) cells, constitute a valuable source of human differentiated cells, including cardiomyocytes. Here, we will focus on cardiac induction of iPS cells, showing how to use them to obtain functional human cardiomyocytes through an embryoid bodies-based protocol.

İnsan kardiyomiyositleri Üretimi: Besleyici-ücretsiz İnsan Bağlı Pluripotent Kök Hücre A Farklılaşma Protokolü

In order to investigate the events driving heart development and to determine the molecular mechanisms leading to myocardial diseases in humans, it is ...

Induction and Analysis of Epithelial to Mesenchymal Transition

Epithelial to mesenchymal transition (EMT) is essential for proper morphogenesis during development. Misregulation of this process has been implicated as a key event in fibrosis and the progression of carcinomas to a metastatic state. Understanding the processes that underlie EMT is imperative for the early diagnosis and clinical control of these disease states. Reliable induction of EMT in vitro is a useful tool for drug discovery as well as to identify common gene expression signatures for diagnostic purposes. Here we demonstrate a straightforward method for the induction of EMT in a variety of cell types. Methods for the analysis of cells pre- and post-EMT induction by immunocytochemistry are also included. Additionally, we demonstrate the effectiveness of this method through antibody-based array analysis and migration/invasion assays.

A straightforward method is described for the induction of epithelial to mesenchymal transition (EMT) in a variety of cell types. Methods for the analysis of cells in EMT states by immunocytochemistry are included.

Mezenkimal Geçiş indüksiyon ve Epitel Analizi

Epithelial  to mesenchymal transition (EMT) is essential for proper morphogenesis during  development. Misregulation of this  process has been implicated ...

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus

A few years ago, the establishment of human induced pluripotent stem cells (iPSCs) ushered in a new era in biomedicine. Potential uses of human iPSCs include modeling pathogenesis of human genetic diseases, autologous cell therapy after gene correction, and personalized drug screening by providing a source of patient-specific and symptom relevant cells. However, there are several hurdles to overcome, such as eliminating the remaining reprogramming factor transgene expression after human iPSCs production. More importantly, residual transgene expression in undifferentiated human iPSCs could hamper proper differentiations and misguide the interpretation of disease-relevant in vitro phenotypes. With this reason, integration-free and/or transgene-free human iPSCs have been developed using several methods, such as adenovirus, the piggyBac system, minicircle vector, episomal vectors, direct protein delivery and synthesized mRNA. However, efficiency of reprogramming using integration-free methods is quite low in most cases.
Here, we present a method to isolate human iPSCs by using Sendai-virus (RNA virus) based reprogramming system. This reprogramming method shows consistent results and high efficiency in cost-effective manner.

Here, we present our established method to reprogram human somatic cells into transgene-free human iPSCs with Sendai virus, which shows consistent outcome and enhanced efficiency.

Sendai-virüs ile İnsan Somatik Verimli Üretimi İnsan uyarılmış pluripotent kök hücrelerin

A few years ago, the establishment of human induced pluripotent stem cells (iPSCs) ushered in a new era in biomedicine. Potential uses of human iPSCs ...